Literature DB >> 16702318

Maternal fish oil supplementation during lactation does not affect blood pressure, pulse wave velocity, or heart rate variability in 2.5-y-old children.

Anni Larnkjaer1, Jeppe H Christensen, Kim F Michaelsen, Lotte Lauritzen.   

Abstract

Maternal (n-3) PUFA deficiency is associated with higher blood pressure (BP) later in life in rat offspring, and early intake of (n-3) PUFA in formula-fed infants was shown to modify later BP. BP, heart rate (HR), and heart rate variability (HRV) are affected by dietary (n-3) PUFA in adults. In this study, we investigated whether fish oil (FO) supplementation of lactating mothers could modify BP, pulse wave velocity (PWV), and HRV in their children after 2 y. Mothers with low fish intake were randomly assigned to FO or olive oil (OO) supplementation for the first 4 mo after delivery. A reference group of mothers with a high habitual fish intake (HFI) was also followed. At the follow-up study at 2.5 y of age, BP and PWV were measured, and electrocardiograms were recorded for 0.5 h. FO supplementation significantly increased RBC levels of long-chain (n-3) PUFA of the 4 mo-old children, but at 2.5 y, the FO and OO groups did not differ. BP, PWV, HR, and HRV also did not differ among the groups. However, for all 3 groups, the children's intake of (n-3) PUFA at 2.5 y was negatively correlated with mean arterial pressure after adjustment for outdoor temperature (r = -0.245, P = 0.04). In conclusion, maternal FO supplementation had no overall effect on BP, PWV, or HRV of the children, indicating that (n-3) PUFA intake of Danish mothers may be sufficient in this sense. However, children's dietary intake of (n-3) PUFA might have a beneficial effect on BP in childhood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702318     DOI: 10.1093/jn/136.6.1539

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

Review 1.  Polyunsaturated fatty acid supplementation in infancy for the prevention of allergy.

Authors:  Tim Schindler; John Kh Sinn; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2016-10-28

2.  Effects on metabolic markers are modified by PPARG2 and COX2 polymorphisms in infants randomized to fish oil.

Authors:  Laurine B S Harsløf; Camilla T Damsgaard; Lars I Hellgren; Anders D Andersen; Ulla Vogel; Lotte Lauritzen
Journal:  Genes Nutr       Date:  2014-03-19       Impact factor: 5.523

Review 3.  Maternal prenatal and/or postnatal n-3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood.

Authors:  Anoja W Gunaratne; Maria Makrides; Carmel T Collins
Journal:  Cochrane Database Syst Rev       Date:  2015-07-22

4.  Omega-3 polyunsaturated Fatty acids and heart rate variability.

Authors:  Jeppe Hagstrup Christensen
Journal:  Front Physiol       Date:  2011-11-16       Impact factor: 4.566

5.  Infant Arterial Stiffness and Maternal Iron Status in Pregnancy: A UK Birth Cohort (Baby VIP Study).

Authors:  Nisreen A Alwan; Janet E Cade; Harry J McArdle; Darren C Greenwood; Helen E Hayes; Etienne Ciantar; Nigel A B Simpson
Journal:  Neonatology       Date:  2015-03-12       Impact factor: 4.035

6.  Breast milk n-3 long-chain polyunsaturated fatty acids and blood pressure: an individual participant meta-analysis.

Authors:  Lenie van Rossem; Henriette A Smit; Martine Armand; Jonathan Y Bernard; Hans Bisgaard; Klaus Bønnelykke; Signe Bruun; Barbara Heude; Steffen Husby; Henriette B Kyhl; Kim F Michaelsen; Ken D Stark; Carel Thijs; Rebecca K Vinding; Alet H Wijga; Lotte Lauritzen
Journal:  Eur J Nutr       Date:  2020-06-20       Impact factor: 5.614

7.  Omega-3 fatty acid addition during pregnancy.

Authors:  Philippa Middleton; Judith C Gomersall; Jacqueline F Gould; Emily Shepherd; Sjurdur F Olsen; Maria Makrides
Journal:  Cochrane Database Syst Rev       Date:  2018-11-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.